The Glyconeer®
Fully Automated Oligosaccharide Synthesizer, since 2013
GlycoUniverse GmbH & Co. KGaA (Potsdam, Germany) is an exclusive supplier of world's first automated oligosaccharide synthesizer Glyconeer®, dedicates to advance carbohydrate-based research.
About Glyconeer®: It is the world's first commercial automated oligosaccharide synthesizer, produced under exclusive licensing terms with MIT (Patent: PCT/US2001/025859) since 2013 and Max-Planck-Institute (Patents: PCT/EP2020/080922; PCT/EP2020/080979; PCT/EP2020/080964) since 2022. Twenty Glyconeers were delivered to international research centers, universities and companies in Germany, Austria, Italy, Great Britain, Spain, the Netherlands, China, Taiwan, Canada, Israel, Saudi Arabia, the United States of America, India, Singapore.
Glyconeer® Network
A fast growing community
Features & Specifications
The all-new Glyconeer® Discover model pushes the limits of what's possible on Automated Glycan Assembly (AGA) technology.
About Glyconeer®: It is the world's first commercial automated oligosaccharide synthesizer, produced under exclusive licensing terms with MIT (Patent: PCT/US2001/025859) since 2013 and Max-Planck-Institute (Patents: PCT/EP2020/080922; PCT/EP2020/080979; PCT/EP2020/080964) since 2022. Twenty Glyconeers were delivered to international research centers, universities and companies in Germany, Austria, Italy, Great Britain, Spain, the Netherlands, China, Taiwan, Canada, Israel, Saudi Arabia, the United States of America, India, Singapore.
Automated Glycan Assembly (AGA)
Take a closer look at the technology behind the Glyconeer®
Application Highlights
Find a glycan structure. Glyconeer® makes it.
Glycan Standards
Highest grade and purity Ultra-sensitive experiments (e.g. IM-MS, IRMPD)
